Dolphin Medical Services Ltd (526504)
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Dolphin Medical's revenue was ₹0.2 Cr (+21.2% year on year, +8.4% on the previous quarter), and net profit ₹0.0 Cr (-40.7% year on year); the operating margin was 15.5%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹0.2 | +21.2% | +8.4% |
| Operating profit | ₹0.0 | +6.7% | +60.0% |
| Net profit | ₹0.0 | -40.7% | +78.0% |
| EPS (₹) | 0.11 | +450.0% | — |
| Operating margin | 15.5% | — | — |
📢 Recent Corporate Announcements
Dolphin Medical Services Ltd has appointed Mr. Amarandhar Reddy Kotha as Chairman and Promoter Director effective September 21, 2026. Mr. Kotha brings 25 years of experience in Information Technology, Networking, and Cyber Security domains. Additionally, Director Rajesh Kumar Mallour has been reclassified from Professional to Promoter category, and the board has approved reconstituting various board committees. The micro-cap company currently operates with an annualized TTM revenue of approximately Rs 1 Cr and a market cap of Rs 2 Cr.
- Appointment of Mr. Amarandhar Reddy Kotha (DIN: 07425226) as Chairman and Promoter Director effective 21st September 2026
- Appointee brings 25 years of experience in IT, networking, and cyber security domains
- Reclassification of Mr. Rajesh Kumar Mallour (DIN: 08125774) from Professional Director to Promoter Director
- Board authorized regulatory filings for the proposed reclassification of Promoter/Promoter Group
Dolphin Medical Services Ltd has appointed Mr. Amarandhar Reddy Kotha as Chairman and Promoter Director effective September 21, 2026. Mr. Kotha brings 25 years of experience in Information Technology, Networking, and Cyber Security domains. Additionally, Director Rajesh Kumar Mallour has been reclassified from Professional to Promoter category, and the board has approved reconstituting various board committees. The micro-cap company currently operates with an annualized TTM revenue of approximately Rs 1 Cr and a market cap of Rs 2 Cr.
- Appointment of Mr. Amarandhar Reddy Kotha (DIN: 07425226) as Chairman and Promoter Director effective 21st September 2026
- Appointee brings 25 years of experience in IT, networking, and cyber security domains
- Reclassification of Mr. Rajesh Kumar Mallour (DIN: 08125774) from Professional Director to Promoter Director
- Board authorized regulatory filings for the proposed reclassification of Promoter/Promoter Group
Dolphin Medical Services Ltd has scheduled a Board Meeting for September 21, 2026, to consider appointing Mr. Amarandhar Reddy Kotha as Chairman and Promoter Director. The Board will also evaluate reclassifying Director Rajesh Kumar Mallour from Professional to Promoter category, along with committee reconstitutions. Additionally, the filing mentions filings related to the reclassification of the Promoter Group post completion of applicable open offer compliances. This signals potential management and control restructuring for a micro-cap company with a market cap of approximately Rs 2 Cr.
- Board meeting scheduled for Monday, September 21, 2026 at 11:00 AM
- Proposal to appoint Mr. Amarandhar Reddy Kotha (DIN: 07425226) as Chairman and Promoter Director
- Proposal to change category of Mr. Rajesh Kumar Mallour to Promoter from Professional
- Reclassification of Promoter Group subject to completion of applicable open offer compliances
Dolphin Medical Services Limited has received approval from the Registrar of Companies (ROC), Telangana, granting a 2-month extension to hold its Annual General Meeting (AGM) for FY26. The AGM, originally due by September 30, 2026, can now be conducted up to November 30, 2026. The approval under Section 96 of the Companies Act, 2013 was issued on August 31, 2026, following the company's application dated August 11, 2026. The exact date for the AGM will be announced in due course.
- ROC Telangana approved a 2-month extension for holding the FY26 AGM
- Extended AGM deadline set for November 30, 2026 (originally due September 30, 2026)
- ROC approval order issued under Section 96(1) on August 31, 2026
- Application was submitted by the company on August 11, 2026 (SRN AC5243512)
Rarever Financial Advisors has released the post-offer advertisement regarding the open offer for Dolphin Medical Services Ltd by Mr. Amarandhar Reddy Kotha and Mr. Mallour Rajesh Kumar. Against an offer size of 39,25,988 shares (26.00%) at ₹4.80 per share, only 18,000 shares (0.12%) were tendered and accepted. Combined with 31,63,390 shares (20.95%) acquired via Share Purchase Agreement (SPA), the acquirers now hold 31,82,717 equity shares, representing 21.08% of total equity share capital.
- Open offer completed at ₹4.80 per share against an offer size of 39,25,988 shares (26.00%).
- Only 18,000 shares (0.12%) tendered and accepted, resulting in total offer payout of ₹86,400.
- SPA acquisition accounted for 31,63,390 shares (20.95% of equity capital).
- Post-offer, total promoter & promoter group holding stands at 26.57% (Acquirers: 21.08%, Existing Promoters: 5.49%).
Dolphin Medical Services reported a 22.2% YoY growth in revenue from operations to Rs 20.60 lakh for Q1 FY27 compared to Rs 16.86 lakh in Q1 FY26. However, net profit fell 43.1% YoY to Rs 1.78 lakh from Rs 3.13 lakh in Q1 FY26 due to higher operational and employee expenses. On a sequential basis, revenue grew 7.3% from Rs 19.20 lakh in Q4 FY26, with net profit rising from Rs 0.71 lakh. The company continues to operate at a micro scale with TTM turnover hovering around Rs 1 crore.
- Revenue from operations grew 22.2% YoY to Rs 20.60 lakh vs Rs 16.86 lakh in Q1 FY26
- Net profit stood at Rs 1.78 lakh, down 43.1% YoY from Rs 3.13 lakh but up from Rs 0.71 lakh in Q4 FY26
- Total expenses rose 34.7% YoY to Rs 19.74 lakh, driven by higher materials consumed (Rs 3.50 lakh) and employee costs (Rs 4.70 lakh)
- Reported EPS for the quarter was Rs 0.11 compared to Rs 0.02 in Q1 FY26
- Promoter holding remained constant at 26.44% with zero pledged shares
Dolphin Medical Services reported a 22.2% YoY growth in revenue from operations to ₹20.60 lakh for the quarter ended June 30, 2026, up from ₹16.86 lakh in Q1 FY26. Net profit fell 43.1% YoY to ₹1.78 lakh compared to ₹3.13 lakh in the prior-year period, pressured by higher employee and material expenses. Sequentially, net profit improved from ₹0.71 lakh in Q4 FY26. Total expenses for the quarter expanded 34.7% YoY to ₹19.74 lakh.
- Revenue from operations rose 22.2% YoY to ₹20.60 lakh (vs ₹16.86 lakh in Q1 FY26)
- Net profit dropped 43.1% YoY to ₹1.78 lakh from ₹3.13 lakh in Q1 FY26, though up QoQ from ₹0.71 lakh
- Total expenses rose 34.7% YoY to ₹19.74 lakh from ₹14.65 lakh
- Total income including other income stood at ₹21.52 lakh vs ₹17.78 lakh YoY
Dolphin Medical Services Ltd has scheduled a board meeting for August 14, 2026, to approve its unaudited standalone financial results for the quarter ended June 30, 2026. The company is a micro-cap healthcare provider with a TTM revenue of just ₹1 Cr and a market capitalization of ₹10 Cr. The trading window for insiders has been closed since July 01, 2026, and will reopen 48 hours after the results are announced. Investors should note the company's high P/E ratio of 142.8 despite very low absolute profits.
- Board meeting scheduled for August 14, 2026, to review Q1 FY27 performance
- Trading window for insiders closed from July 01, 2026, until 48 hours post-results
- Company reported a TTM revenue of ₹1 Cr and TTM PAT of ₹0 Cr
- Promoter holding remains stable at 26.44% as of June 2026
Mr. Amarandhar Reddy Kotha and Mr. Mallour Rajesh Kumar are launching an open offer to acquire 39,25,988 equity shares, representing 26% of Dolphin Medical Services. The offer price is set at ₹4.80 per share, which is a significant discount to the current market price of ₹7.5. The tendering period will run from July 31, 2026, to August 13, 2026. The Committee of Independent Directors has recommended the offer as fair and reasonable per SEBI regulations.
- Open offer to acquire 39,25,988 equity shares representing 26% of the voting capital
- Offer price fixed at ₹4.80 per share, payable in cash
- Tendering period scheduled from July 31, 2026, to August 13, 2026
- Acquirers' total shareholding post-offer will be capped at 75% to maintain minimum public shareholding
- Offer price of ₹4.80 is approximately 36% below the current market price of ₹7.5
Mr. Amarandhar Reddy Kotha and Mr. Mallour Rajesh Kumar have issued a formal Letter of Offer to acquire up to 39,25,988 equity shares (26% stake) of Dolphin Medical Services. The offer price is set at ₹4.80 per share, which represents a significant discount of approximately 39% compared to the current market price of ₹7.9. The tendering period is scheduled to open on July 31, 2026, and close on August 13, 2026. This move follows a potential change in control or substantial acquisition under SEBI (SAST) Regulations for this micro-cap healthcare provider.
- Open offer to acquire 39,25,988 equity shares representing 26.00% of the voting capital
- Offer price fixed at ₹4.80 per share, significantly below the current market price of ₹7.9
- Tendering period scheduled from July 31, 2026, to August 13, 2026
- Total potential outlay for the offer is approximately ₹1.88 Cr based on the offer price
- Identified date for determining eligible public shareholders was July 17, 2026
Dolphin Medical Services Ltd has announced the resignation of Ms. Vaishnavi Sharma from the dual roles of Chief Financial Officer (CFO) and Company Secretary (CS) cum Compliance Officer. The resignation was accepted by the Board on July 25, 2026, with the cessation effective from July 24, 2026. For a micro-cap company with a market capitalization of just ₹11 Cr and TTM revenue of ₹1 Cr, the exit of a key management person (KMP) handling both finance and compliance is a notable event. The company has not yet announced a successor for these statutory positions.
- Resignation of Ms. Vaishnavi Sharma from the posts of CFO and Company Secretary effective July 24, 2026
- Board meeting for approval conducted on July 25, 2026, between 4:30 P.M. and 5:00 P.M.
- Company operates at a small scale with TTM revenue of only ₹1 Cr
- Promoter holding remains constant at 26.44% as of June 2026
- Market capitalization of the company is approximately ₹11 Cr
Dolphin Medical Services has announced the resignation of Vaishnavi Sharma from the dual roles of Company Secretary cum Compliance Officer and Chief Financial Officer (CFO). The resignation was accepted by the Board on July 25, 2026, with the cessation effective from July 24, 2026. This is a significant leadership change for a micro-cap company with a market capitalization of only ₹11 Cr and TTM revenue of ₹1 Cr. Investors should monitor the appointment of a successor to ensure continuity in regulatory compliance and financial oversight.
- Resignation of the individual holding three key roles: CS, Compliance Officer, and CFO.
- Cessation of office effective from the close of business hours on July 24, 2026.
- Board meeting for approval conducted on July 25, 2026, lasting 30 minutes (4:30 PM to 5:00 PM).
- Company operates on a very small scale with TTM revenue of just ₹1 Cr and PAT of ₹0 Cr.
- Promoter holding remains stagnant at 26.44% as of June 2026.
Dolphin Medical Services is undergoing a change in control with an open offer by Mr. Amarandhar Reddy Kotha and Mr. Mallour Rajesh Kumar to acquire up to 39,25,988 shares (26% stake). The offer price is fixed at ₹4.80 per share, which is a significant ~41% discount to the current market price of ₹8.2. The company has now fixed July 17, 2026, as the 'Identified Date' to determine the shareholders who will receive the formal Letter of Offer. This is a procedural step in the takeover process initiated in May 2026.
- Open offer for 39,25,988 fully paid-up equity shares representing 26.00% of voting capital
- Offer price set at ₹4.80 per share, compared to the current market price of ₹8.2
- Identified date for determining eligible shareholders fixed as July 17, 2026
- Acquisition led by two individual acquirers: Mr. Amarandhar Reddy Kotha and Mr. Mallour Rajesh Kumar
- Process managed by Rarever Financial Advisors Private Limited
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
